Company News
12/14/2021
Prestigious annual pediatric medical device competition takes aim at congenital heart disease with five innovators sharing $150K in NCC-PDI grants
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces five awardees chosen in its prestigious annual “Make Your Medical Device Pitch for Kids!” competition to share $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) to support the advancement of pediatric medical devices. In an unprecedented decision, the competition judges determined that all …
12/14/2021
HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer
Industry Veteran Will Lead HST5040 and Future Rare Disease Clinical Programs HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare metabolic disorders, has appointed Patrick Horn, MD, PhD, as Chief Medical Officer, effective January 1, 2022. Dr. Horn will lead the company’s growing clinical operations, clinical development, regulatory affairs, medical affairs, biometrics …
12/13/2021
Advanced Pharmaceutical Cluster Growth Project Chosen As Finalist In EDA’s Build Back Better Regional Challenge
The coalition will compete for up to $100 million to supercharge the economy of Central Virginia The coalition of public and private organizations in support of creating an advanced pharmaceutical cluster in Central Virginia was named by the Economic Development Administration (EDA) as a finalist in the $1 billion Build Back Better Regional Challenge. The …
12/13/2021
RIVANNA® Announces Partnership With BOMImed to Increase Distribution of Accuro® in Canada
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with BOMImed, a recognized manufacturer of anesthesia and critical care related consumables to represent and distribute the Accuro® portfolio of products in Canada. BOMImed is a choice distribution partner for RIVANNA as its focus is within the fields of anesthesia and critical …
12/10/2021
Virginia Catalyst Announces Round 13 of Grant Funding! Could you use $200,000 to $800,000 in a Non-Dilutive Grant?
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 13 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “When you combine world class research with …
12/09/2021
Adial Announces Cary J. Claiborne has Joined the Company as Chief Operating Officer
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Cary J. Claiborne as Chief Operating Officer. Mr. Claiborne will continue to serve on the Board of Directors. In his new role, Mr. Claiborne will be responsible for overseeing …